T11	Disease 851 879	oral squamous cell carcinoma
#2	AnnotatorNotes T11	DOID:0050866
T13	Disease 893 907	bladder cancer
#4	AnnotatorNotes T13	DOID:11054
T16	Drug 1177 1187	paclitaxel
T17	Disease 1202 1217	prostate cancer
#7	AnnotatorNotes T17	DOID:10283
T18	Disease 1231 1244	breast cancer
#8	AnnotatorNotes T18	DOID:1612
T2	Biomarker 194 215	lymph node metastasis
T23	Disease 1579 1596	esophageal cancer
#11	AnnotatorNotes T23	DOID:5041
T24	Disease 1601 1615	gastric cancer
#12	AnnotatorNotes T24	DOID:10534
T3	Disease 271 282	lung cancer
#13	AnnotatorNotes T3	DOID:1324
T8	Disease 541 565	hepatocellular carcinoma
#16	AnnotatorNotes T8	DOID:684
T4	Gene-Protein 83 88	KRT18
#6	AnnotatorNotes T4	HGNC:6430
T5	Gene-Protein 108 113	KRT18
T9	Gene-Protein 293 298	KRT18
T10	Gene-Protein 586 591	KRT18
T14	Gene-Protein 398 403	KRT18
T19	Gene-Protein 734 739	KRT18
T20	Gene-Protein 970 975	KRT18
T21	Gene-Protein 1622 1627	KRT18
T25	Gene-Protein 1464 1469	KRT18
T26	Gene-Protein 1301 1306	KRT18
T27	Gene-Protein 1126 1131	KRT18
T28	Biomarker 103 124	high KRT18 expression
T29	Biomarker 217 235	distant metastasis
T30	Biomarker 241 266	degree of differentiation
T1	Biomarker 172 192	tumor invasion depth
T31	Biomarker 156 170	clinical stage
T32	Biomarker 293 309	KRT18 expression
T33	Biomarker 346 376	clinical lymph node metastasis
T34	Disease 441 468	high metastatic lung cancer
#1	AnnotatorNotes T34	not found
T6	Biomarker 398 437	KRT18 expression had 4.6-times increase
R1	Association Arg1:T6 Arg2:T34	
T35	Disease 493 519	low metastatic lung cancer
#9	AnnotatorNotes T35	not found
T7	Biomarker 576 602	levels of KRT18 expression
T36	Biomarker 635 656	lymph node metastasis
T37	Biomarker 661 681	aggressive phenotype
T38	Biomarker 734 754	KRT18 overexpression
T39	Biomarker 775 798	advanced clinical stage
T40	Biomarker 800 820	poor differentiation
T41	Biomarker 826 846	high invasion patter
T12	Biomarker 970 975	KRT18
T42	Biomarker 1107 1131	high expression of KRT18
#3	AnnotatorNotes T16	CHEMBL428647
R2	Mediated-Non-Response Arg1:T16 Arg2:T17	
R3	Mediator Arg1:T16 Arg2:T42	
T15	Biomarker 1152 1172	tumor aggressiveness
T43	Biomarker 1282 1306	high expression of KRT18
T44	Disease 1325 1334	luminal B
#5	AnnotatorNotes T44	DOID:0080674
T45	Disease 1387 1396	luminal A
#14	AnnotatorNotes T45	DOID:0060548
T46	Collection 1325 1396	luminal B patients from Lebanon, Tunisia, and Morocco, and in luminal A
R4	Association Arg1:T43 Arg2:T46	
T47	Biomarker 1464 1480	KRT18 expression
T22	Biomarker 1512 1526	clinical stage
T48	Biomarker 1528 1539	tumor stage
T49	Biomarker 1545 1561	metastasis stage
T50	Biomarker 1617 1638	high KRT18 expression
T51	Biomarker 1675 1695	positive lymph nodes
T52	Biomarker 1697 1720	advanced clinical stage
#10	AnnotatorNotes T12	C488421
R5	Association Arg1:T12 Arg2:T13	
